Calamos Wealth Management LLC grew its holdings in Morgan Stanley (NYSE:MS) by 22.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 38,682 shares of the financial services provider’s stock after acquiring an additional 6,996 shares during the period. Calamos Wealth Management LLC’s holdings in Morgan Stanley were worth $1,863,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors have also bought and sold shares of MS. BlackRock Inc. grew its stake in shares of Morgan Stanley by 2,798.9% in the first quarter. BlackRock Inc. now owns 101,168,197 shares of the financial services provider’s stock worth $4,334,046,000 after acquiring an additional 97,678,337 shares in the last quarter. Janus Henderson Group PLC grew its stake in shares of Morgan Stanley by 5,268.0% during the second quarter. Janus Henderson Group PLC now owns 9,590,843 shares of the financial services provider’s stock worth $427,365,000 after purchasing an additional 9,412,177 shares in the last quarter. Epoch Investment Partners Inc. acquired a new position in shares of Morgan Stanley during the first quarter worth $215,402,000. Lazard Asset Management LLC grew its stake in shares of Morgan Stanley by 801.0% during the second quarter. Lazard Asset Management LLC now owns 5,321,327 shares of the financial services provider’s stock worth $237,117,000 after purchasing an additional 4,730,704 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA grew its stake in shares of Morgan Stanley by 64.6% during the first quarter. Massachusetts Financial Services Co. MA now owns 11,162,183 shares of the financial services provider’s stock worth $478,188,000 after purchasing an additional 4,380,706 shares in the last quarter. Institutional investors and hedge funds own 85.09% of the company’s stock.
Morgan Stanley (MS) traded down 0.77% during mid-day trading on Monday, hitting $50.52. 966,463 shares of the stock traded hands. The firm has a market cap of $91.54 billion, a PE ratio of 14.03 and a beta of 1.61. The stock has a 50 day moving average price of $48.54 and a 200 day moving average price of $45.57. Morgan Stanley has a 12-month low of $32.56 and a 12-month high of $51.52.
Morgan Stanley (NYSE:MS) last released its earnings results on Tuesday, October 17th. The financial services provider reported $0.93 earnings per share for the quarter, topping the consensus estimate of $0.81 by $0.12. The business had revenue of $9.20 billion for the quarter, compared to the consensus estimate of $9.05 billion. Morgan Stanley had a net margin of 16.76% and a return on equity of 10.11%. The firm’s quarterly revenue was up 3.2% compared to the same quarter last year. During the same period last year, the firm posted $0.80 earnings per share. On average, analysts expect that Morgan Stanley will post $3.60 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, November 15th. Stockholders of record on Tuesday, October 31st will be given a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 1.95%. The ex-dividend date of this dividend is Monday, October 30th. Morgan Stanley’s dividend payout ratio (DPR) is currently 27.70%.
A number of equities analysts recently commented on MS shares. Zacks Investment Research downgraded shares of Morgan Stanley from a “hold” rating to a “sell” rating in a research note on Tuesday, July 11th. Credit Suisse Group upgraded shares of Morgan Stanley from a “neutral” rating to an “outperform” rating and boosted their target price for the stock from $49.00 to $54.00 in a research note on Monday, October 9th. ValuEngine downgraded shares of Morgan Stanley from a “strong-buy” rating to a “buy” rating in a research note on Friday, September 1st. Wells Fargo & Company started coverage on shares of Morgan Stanley in a research note on Wednesday, August 9th. They set a “market perform” rating and a $48.00 target price for the company. Finally, Buckingham Research boosted their target price on shares of Morgan Stanley from $54.00 to $57.00 and gave the stock a “buy” rating in a research note on Wednesday, October 18th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, eighteen have given a buy rating and two have given a strong buy rating to the stock. Morgan Stanley presently has a consensus rating of “Buy” and a consensus price target of $50.39.
In related news, insider Jeffrey S. Brodsky sold 16,397 shares of the business’s stock in a transaction that occurred on Wednesday, October 18th. The shares were sold at an average price of $50.07, for a total transaction of $820,997.79. Following the transaction, the insider now directly owns 111,776 shares of the company’s stock, valued at $5,596,624.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, President Thomas Colm Kelleher sold 40,000 shares of the business’s stock in a transaction that occurred on Monday, October 23rd. The shares were sold at an average price of $50.59, for a total transaction of $2,023,600.00. Following the transaction, the president now directly owns 692,037 shares in the company, valued at $35,010,151.83. The disclosure for this sale can be found here. Over the last three months, insiders sold 268,763 shares of company stock worth $12,881,015. 0.24% of the stock is currently owned by insiders.
Morgan Stanley Profile
Morgan Stanley is a financial holding company. The Company’s segments include Institutional Securities, Wealth Management and Investment Management. The Company’s Institutional Securities business segment provides investment banking, sales and trading, and other services to corporations, governments, financial institutions and high-to-ultra high net worth clients.
What are top analysts saying about Morgan Stanley? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Morgan Stanley and related companies.